Bio/Pharma News

Jul 17, 2018
By Pharmaceutical Technology Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 16, 2018
By Pharmaceutical Technology Editors
Otsuka Pharmaceutical will acquire Visterra, a clinical-stage biotechnology company focused on developing antibody-based therapies, for approximately $430 million.
Jul 11, 2018
By Pharmaceutical Technology Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 11, 2018
By Pharmaceutical Technology Editors
The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.
Jul 11, 2018
By Pharmaceutical Technology Editors
Teva Pharmaceuticals USA will move its US headquarters to Parsippany-Troy Hills, NJ.
Jul 10, 2018
By Pharmaceutical Technology Editors
Certain blister card packages that do not meet US child-resistant packaging requirements are being recalled because they pose a risk of harm if the tablets are swallowed by children.
Jul 09, 2018
By Pharmaceutical Technology Editors
The company opened its new global headquarters in Japan.
Jul 06, 2018
By Pharmaceutical Technology Editors
Sanofi will open a R&D operations hub in Chengdu, Sichuan province, China, with a focus on digitalization and big data analysis.
Jul 03, 2018
By Pharmaceutical Technology Editors
The pharma major intends to spinoff Alcon as a stand-alone eye-care devices company.
Jul 03, 2018
By Pharmaceutical Technology Editors
Biogen will pay Samsung BioLogics approximately $700 million to increase its stake in Samsung Bioepis to approximately 49.9%.
native1_300x100
lorem ipsum